A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole

• Κύριοι συγγραφείς: Mohsin Hamid (Συγγραφέας), Bilal Lashari (Συγγραφέας), Irfan Ahsan (Συγγραφέας), Ida Micaily (Συγγραφέας), Usman Sarwar (Συγγραφέας), Joseph Crocetti (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Greater Baltimore Medical Center, 2018-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. Trimethoprim-sulfamethoxazole (TS) is one of the most widely prescr...